Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus doxycycline for hidradenitis suppurativa
NL-OMON25659Not yet recruiting
- Sponsor
- ZonMw
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in hidradenitis suppurativa (HS) comparing Metformin plus doxycycline with Doxycycline monotherapy (2 arms). Primary endpoint: International Hidradenitis Suppurativa Severity Score System. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
metformindoxycycline
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NL-OMON25659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25659.